GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Synektik SA (FRA:A2P) » Definitions » Gross Margin %

Synektik (FRA:A2P) Gross Margin % : 39.17% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Synektik Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Synektik's Gross Profit for the three months ended in Mar. 2024 was €7.9 Mil. Synektik's Revenue for the three months ended in Mar. 2024 was €20.1 Mil. Therefore, Synektik's Gross Margin % for the quarter that ended in Mar. 2024 was 39.17%.


The historical rank and industry rank for Synektik's Gross Margin % or its related term are showing as below:

FRA:A2P' s Gross Margin % Range Over the Past 10 Years
Min: 11.77   Med: 23.86   Max: 29.57
Current: 29.57


During the past 12 years, the highest Gross Margin % of Synektik was 29.57%. The lowest was 11.77%. And the median was 23.86%.

FRA:A2P's Gross Margin % is ranked worse than
80.38% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 52.61 vs FRA:A2P: 29.57

Synektik had a gross margin of 39.17% for the quarter that ended in Mar. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Synektik was 5.00% per year.


Synektik Gross Margin % Historical Data

The historical data trend for Synektik's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synektik Gross Margin % Chart

Synektik Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Sep18 Sep19 Sep20 Sep21 Sep22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.50 24.18 24.45 23.53 29.07

Synektik Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.79 32.46 32.66 23.85 39.17

Competitive Comparison of Synektik's Gross Margin %

For the Medical Devices subindustry, Synektik's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synektik's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Synektik's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Synektik's Gross Margin % falls into.



Synektik Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Synektik's Gross Margin for the fiscal year that ended in Sep. 2022 is calculated as

Gross Margin % (A: Sep. 2022 )=Gross Profit (A: Sep. 2022 ) / Revenue (A: Sep. 2022 )
=11.1 / 38.327
=(Revenue - Cost of Goods Sold) / Revenue
=(38.327 - 27.186) / 38.327
=29.07 %

Synektik's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=7.9 / 20.145
=(Revenue - Cost of Goods Sold) / Revenue
=(20.145 - 12.254) / 20.145
=39.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Synektik  (FRA:A2P) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Synektik had a gross margin of 39.17% for the quarter that ended in Mar. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Synektik Gross Margin % Related Terms

Thank you for viewing the detailed overview of Synektik's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Synektik (FRA:A2P) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aleja Wincentego Witosa 31, Warsaw, POL, 00-710
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.

Synektik (FRA:A2P) Headlines

No Headlines